Cargando…

Editorial Commentary: Polymyxin-Resistant Acinetobacter baumannii: Urgent Action Needed

Detalles Bibliográficos
Autores principales:	Pogue, Jason M., Cohen, David A., Marchaim, Dror
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392843/ https://www.ncbi.nlm.nih.gov/pubmed/25632011 http://dx.doi.org/10.1093/cid/civ044

Ejemplares similares

RapidResa Polymyxin Acinetobacter NP(®) Test for Rapid Detection of Polymyxin Resistance in Acinetobacter baumannii
por: Bouvier, Maxime, et al.
Publicado: (2021)

A novel decoy strategy for polymyxin resistance in Acinetobacter baumannii
por: Park, Jaeeun, et al.
Publicado: (2021)

Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii
por: Mahamad Maifiah, Mohd Hafidz, et al.
Publicado: (2016)

Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance
por: Zhu, Yan, et al.
Publicado: (2020)

Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant Acinetobacter baumannii with Polymyxin-Based Combinations
por: Wences, Marisol, et al.
Publicado: (2022)

PKPD Modeling of the Inoculum Effect of Acinetobacter baumannii on Polymyxin B in vivo
por: Chauzy, Alexia, et al.
Publicado: (2022)

Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates
por: Barin, Juliana, et al.
Publicado: (2013)

Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii
por: Chung, Joon-hui, et al.
Publicado: (2016)

Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii
por: Tran, Thien B., et al.
Publicado: (2015)

Commentary: Renal replacement therapy in cardiac surgery patients: An urgent need for consensus
por: Bustamante-Munguira, Juan, et al.
Publicado: (2021)

Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study
por: Tran, Thien B., et al.
Publicado: (2018)

Urgent need to take action on reducing postoperative respiratory complications
por: Le, Lan My, et al.
Publicado: (2021)

Strategies for Rapid Identification of Acinetobacter baumannii Membrane Proteins and Polymyxin B’s Effects
por: Lu, Yun, et al.
Publicado: (2021)

In vitro antibacterial activity of combinations of fosfomycin, minocycline and polymyxin B on pan-drug-resistant Acinetobacter baumannii
por: ZHANG, YAJUN, et al.
Publicado: (2013)

Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens
por: Cheah, Soon-Ee, et al.
Publicado: (2016)

In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
por: Zhang, Hui, et al.
Publicado: (2021)

Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-Resistant Acinetobacter baumannii Pneumonia
por: Hu, Guangxue, et al.
Publicado: (2022)

Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant Acinetobacter baumannii
por: Zhu, Shixing, et al.
Publicado: (2022)

Commentary: COVID-19 and obesity pandemics converge into a syndemic requiring urgent and multidisciplinary action
por: Hill, Michael A., et al.
Publicado: (2021)

COP27 Climate Change Conference: urgent action needed for Africa and the world
por: Atwoli, Lukoye, et al.
Publicado: (2022)

Polymyxin Resistance Among XDR ST1 Carbapenem-Resistant Acinetobacter baumannii Clone Expanding in a Teaching Hospital
por: Carrasco, Letícia Dias de Melo, et al.
Publicado: (2021)

Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii
por: Chang, Kang, et al.
Publicado: (2022)

In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore
por: Lim, Tze-Peng, et al.
Publicado: (2011)

Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report
por: Guo, Wei, et al.
Publicado: (2018)

Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapy
por: Fedrigo, Nayara Helisandra, et al.
Publicado: (2021)

In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii [Corrigendum]
Publicado: (2021)

551. Burden of Illness in Carbapenem-Resistant Acinetobacter baumannii Infections in US Hospitals (2014 to 2018)
por: Pogue, Jason M, et al.
Publicado: (2019)

Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019
por: Pogue, Jason M., et al.
Publicado: (2022)

Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation
por: Sato, Yoshinori, et al.
Publicado: (2018)

Comparative Genomics of Two ST 195 Carbapenem-Resistant Acinetobacter baumannii with Different Susceptibility to Polymyxin Revealed Underlying Resistance Mechanism
por: Lean, Soo-Sum, et al.
Publicado: (2016)

Attributable mortality of Acinetobacter baumannii: no longer a controversial issue
por: Falagas, Matthew E, et al.
Publicado: (2007)

Acinetobacter baumannii ophthalmia neonatorum – A very rare presentation
por: Das, Gunasagar
Publicado: (2023)

Prevalence and Genetic Characterization of Carbapenem- and Polymyxin-Resistant Acinetobacter baumannii Isolated from a Tertiary Hospital in Terengganu, Malaysia
por: Lean, Soo-Sum, et al.
Publicado: (2014)

Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
por: Lyu, Cheng, et al.
Publicado: (2020)

Changing trends of population and blindness in Oman: A need for urgent action
por: Khandekar, Rajiv, et al.
Publicado: (2012)

Polymyxin-Resistant Acinetobacter spp. Isolates: What is Next?
por: Reis, Adriana O., et al.
Publicado: (2003)

Beyond the Safe Motherhood Initiative: Accelerated Action Urgently Needed to End Preventable Maternal Mortality
por: Stanton, Mary Ellen, et al.
Publicado: (2018)

Drug Combination of Ciprofloxacin and Polymyxin B for the Treatment of Multidrug–Resistant Acinetobacter baumannii Infections: A Drug Pair Limiting the Development of Resistance
por: Wang, Junwei, et al.
Publicado: (2023)

COP27 Climate Change Conference: urgent action needed for Africa and the world
por: Atwoli, Lukoye, et al.
Publicado: (2022)

6-Bromo-2-naphthol from Silene armeria extract sensitizes Acinetobacter baumannii strains to polymyxin
por: Kang, Mingyeong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ki7beko0usd8848lp24spg1bnf